Clinical Trials · NCT07374328

Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellitus

RecruitingPhase 1/Phase 2Semaglutide (Investigational)
Phase
Phase 1/Phase 2
Recruitment status
Recruiting
Sponsor
Second Affiliated Hospital of Guangzhou Medical University
Enrollment
240
Start date
Jun 2025
Locations
1 site, China
Primary endpoint
Diabetes remission rate
View Semaglutide compound reference